Bacterial Competition and Colicin Biology

Bacteria inhabit densely populated environments in which the struggle for nutrients and space drives the evolution of diverse antagonistic strategies. Among these, proteinaceous toxins known as bacteriocins play a central role in intra‐ and interspecies rivalry. Colicins, narrow‐spectrum bacteriocins produced by Escherichia coli and related species, exemplify this chemical warfare: they bind specific receptors on target cells, translocate across the envelope and deploy nuclease or pore‐forming activities to kill competitors. Beyond colicins, bacteria wield a suite of short‐range contact systems—such as the type VI secretion system and contact‐dependent inhibition—and long‐range diffusible weapons, including tailocins and secreted antimicrobial peptides. The coexistence of multiple weapon systems within single strains suggests distinct functional niches: contact‐dependent effectors excel when attackers are rare or invading structured habitats, while diffusible toxins confer overwhelming advantage when producer populations are abundant. Immunity proteins, co-expressed with colicins, safeguard producers against self‐intoxication and shape competitive dynamics. Insights into molecular recognition, translocation pathways and ecological context have profound implications for understanding microbial community assembly, infection dynamics and the development of novel antimicrobials.

Research from Nature Portfolio

Recent studies have employed agent-based modelling alongside empirical assays to elucidate why bacteria maintain both cell-contact and diffusible weapons. Models predict that contact-dependent systems enable invaders to establish when greatly outnumbered, whereas diffusible toxins are most effective at high density. Experiments with Pseudomonas aeruginosa carrying both contact apparatus and diffusing tailocins confirm these predictions, revealing synergistic deployment when both weapons co-occur. In parallel, research in animal infection models demonstrates the therapeutic potential of protein antibiotics derived from P. aeruginosa. Pyocins, which resemble colicins in specificity and mode of action, protected mice from lethal lung infections at far lower doses than conventional antibiotics. These studies underscore the dual relevance of bacterial competition mechanisms for both ecology and translational microbiology.

Bacterial Competition and Colicin Biology publication trend

The graph below shows the total number of articles in bacterial competition and colicin biology across all publications each year (not limited to Nature Index journals).

Technical terms

Bacteriocin: A protein toxin produced by bacteria that kills or inhibits closely related strains.

Colicin: A class of narrow‐spectrum bacteriocins produced by Escherichia coli, typically with nuclease or pore‐forming activity.

Tailocin: A phage‐tail‐like bacteriocin that acts as a diffusible weapon against susceptible bacteria.

Type VI secretion system: A contact-dependent apparatus that injects toxic effectors directly into neighbouring cells.

Contact-dependent inhibition (CDI): A mechanism whereby toxins are delivered to target cells only upon direct cell–cell contact.

Immunity protein: A specific protein co-produced by the toxin-producer that binds and neutralises its cognate bacteriocin.

References

1. The evolution of short- and long-range weapons for bacterial competition. Nature Ecology & Evolution (2023).
2. Binding Free Energy Analysis of Colicin D, E3 and E8 to Their Respective Cognate Immunity Proteins Using Computational Simulations. Molecules (2025).
3. Synthesis of colicin Ia neoglycoproteins: tools towards glyco-engineering of bacterial cell surfaces. RSC Advances (2024).
4. Efficacy of species-specific protein antibiotics in a murine model of acute Pseudomonas aeruginosa lung infection. Scientific Reports (2016).
5. Diversity and distribution of nuclease bacteriocins in bacterial genomes revealed using Hidden Markov Models. PLOS Computational Biology (2017).